Journal of Cancer Education

, Volume 33, Issue 6, pp 1189–1194 | Cite as

Awareness, Knowledge and Attitudes Towards Cervical Cancer Amongst HIV-Positive Women Receiving Care in a Tertiary Hospital in Nigeria

  • Maxwell O. AdibeEmail author
  • Deborah O. Aluh


The incidence of cervical cancer (CC) in the sub-Saharan Africa region, where Nigeria is located, is amongst the highest in the world; it is estimated that 70,722 new cases of invasive cervical cancer occur annually in sub-Saharan Africa. Immunosuppression, especially due to human immunodeficiency virus (HIV) infection, is a predisposing factor for persistent infection with high-risk human papilloma virus (HR-HPV) and the development of squamous intraepithelial lesions. Four hundred and fifty women who attended the HIV clinic at the Nnamdi Azikiwe University Teaching Hospital, Nnewi, and who consented to participate in the study were randomly selected. They were given self-administered questionnaires which sought to determine their awareness and knowledge of cervical cancer and attitudes towards cervical cancer screening and prevention. The media 23% (n = 103) was the most common source of information amongst respondents who had heard about cervical cancer. For all the women surveyed, the average percentage knowledge was 9.95%. Having attitude scores greater than or equal to the mean attitude score of 55.16% was regarded as having a positive attitude while a score lower than that was regarded as negative attitude. About 43.5% (n = 195) respondents had a positive attitude towards cervical cancer screening and prevention. Cervical cancer awareness and knowledge amongst women attending the HIV clinic in the Nnamdi Azikiwe University Teaching Hospital, Nnewi, were very poor. Their attitude towards cervical cancer screening practices and prevention was also very poor.


Cervical cancer Nigeria Immunosuppression Awareness HIV 


  1. 1.
    Maree JE, Moitse KA (2014) Exploration of knowledge of cervical cancer and cervical cancer screening amongst HIV-positive women. Curationis 37(1):1209, 7 pages.  10.4102/curationis.v37i1.1209
  2. 2.
    Demarteau N, Morhason-Bello IO, Akinwunmi B, Adewole IF (2014) Modeling optimal cervical cancer prevention strategies in Nigeria. BMC Cancer 14:365. doi: 10.1186/1471-2407-14-365 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H (2008) Cancer in indigenous Africans—burden, distribution and trends. Lancet Oncol 9:683–689. doi: 10.1016/s1470-2045(08)70175-x CrossRefPubMedGoogle Scholar
  4. 4.
    Adewole IF, Benedet JL, Crai BT, Follen M (2005) Evolving a strategic approach to cervical cancer control in Africa. GynecolOncol 99:S209–S212. doi: 10.1016/j.ygyno.2005.07.086 CrossRefGoogle Scholar
  5. 5.
    Ogunbode OO, Ayinde OA (2005) Awareness of cervical cancer and screening in a Nigerian female market population. Ann Afr Med 4:160–163Google Scholar
  6. 6.
    Ayinde OA, Omigbodun AO, Ilesanmi OA (2004) Awareness of cervical cancer, Papanicolaou’s smear and its utilisation among female undergraduates in Ibadan. Afr J Reprod Health 8(3):68–80. doi: 10.2307/3583394 CrossRefPubMedGoogle Scholar
  7. 7.
    Abiodun OA, Fatungase OK, Olu-Abiodun OO (2006) Knowledge, perception and predictors of uptake of cervical screening among rural Nigerian women. J Public Health and Epi 6:119–124. doi: 10.5897/jphe2013.0576 CrossRefGoogle Scholar
  8. 8.
    Dim CC (2012) Towards improving cervical cancer screening in Nigeria: a review of basics of cervical neoplasm and cytology. Niger J Clinl Pract 15:247–252CrossRefGoogle Scholar
  9. 9.
    Ononogbu U, Almujtaba M, Modibbo F, Lawal I, Offiong R, Olaniyan O, Dakum P et al (2013) Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health 13:582. doi: 10.1186/1471-2458-13-582 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Akarolo-Anthony NS, Maso L, Igbinoba F, Mbulaiteye MS, Adebamowo CA (2014) Cancer burden among HIV positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infectious Agents Cancer 9:1. doi: 10.1186/1750-9378-9-1 CrossRefPubMedGoogle Scholar
  11. 11.
    Nwozor CM, Oragudosi AL (2014) Awareness and uptake of cervical cancer screening among women in Onitsha, South-East, Nigeria. Greener J Med sci 3(8):283–288. doi: 10.4314/njm.v18i4.51248 CrossRefGoogle Scholar
  12. 12.
    Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios X, Borras J, Parkin DM (2000) International trends in incidence of cervical cancer: squamous-cell carcinoma. Int J Cancer 86(3):429–435. doi: 10.1002/(sici)1097-0215(20000501);2-d CrossRefPubMedGoogle Scholar
  13. 13.
    Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000) Trends in cancer incidence in Kyadondo county, Uganda, 1960–1997. Br J Cancer 82(9):1585–1592CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E, Tuijn C, Wit FW, Umutoni A, Uwineza M, Crucitti T, van de Wijgert JH (2011) The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infect Dis 11:333. doi: 10.1186/1471-2334-11-333 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Putignano G (2005) Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women. Eur J Obstet Gynecol Reprod Biol 121:226–232. doi: 10.1016/j.ejogrb.2004.12.003 CrossRefPubMedGoogle Scholar
  16. 16.
    Sichanh C, Quet F, Chanthavilay P, Diendere J, Latthaphasavang V, Longuet C, Buisson Y (2014) Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR. BMC Cancer 14:161. doi: 10.1186/1471-2407-14-161 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Ezechi OC, Gab-Okafor CV, Ostergen OP, Pettersson KO (2013) Willingness and acceptability of cervical cancer among HIV positive Nigerian women. BMC Public Health 13:14. doi: 10.1186/1471-2458-13-46 CrossRefGoogle Scholar
  18. 18.
  19. 19.
    Dim C, Dim N, Ezegwui H, Ikeme A (2009) An unmet cancer screening need of HIV-positive women in southeastern Nigeria. Medscape J Med 11(1):19PubMedPubMedCentralGoogle Scholar
  20. 20.
    Anorlu RI, Adegbesan M, Adaramewa T (2010) Knowledge of HPV and cervical cancer among HIV-positive women in Lagos, Nigeria. BioMed Central (BMC) Infect Agent Cancer 5(Suppl 1):A46 Retrieved from http://www.biomedcentral/content/pdf/1750-9378-5-S1-info.pdf Google Scholar
  21. 21.
    Rosser JI, Njoroge B, Huchko MJ (2015) Cervical cancer screening knowledge and behavior among women attending an urban HIV Clinic in Western Kenya. J Cancer Educ 30(3):567–572CrossRefPubMedGoogle Scholar
  22. 22.
    Tirivanhu C, Gundani H (2013) Awareness of cervical cancer in HIV positive women aged 18 to 49 years at Bindura Provincial Hospital, Mashonaland Central Province, Zimbabwe. Oriental Journal of Scientific Research 2:1. doi: 10.2989/16085906.2014.901979 CrossRefGoogle Scholar
  23. 23.
    Tebeu P, Major A, Rapiti E, Petignat P, Bouchardy C, Sando Z, de Bernis L, Ali L, Mhawech-Fauceglia P (2008) The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of far North Province of Cameroon. Int J Gynecol Cancer 18:761–765. doi: 10.1111/j.1525-1438.2007.01066.x CrossRefPubMedGoogle Scholar
  24. 24.
    Matangaidze O, Ramalivhana N (2016) Knowledge, attitude and practices of HIV-infected women on cervical cancer screening at a church-affiliated hospital. Journal of Dental and Medical Sciences 15(4):119–126. doi: 10.9790/0853-150407119126s CrossRefGoogle Scholar
  25. 25.
    Awofala A, Ogundele O (2016) HIV Epidemiology in Nigeria. Saudi Journal of Biological sciences. Available online.

Copyright information

© American Association for Cancer Education 2017

Authors and Affiliations

  1. 1.Department of Clinical Pharmacy and Pharmacy ManagementUniversity of NigeriaNsukkaNigeria
  2. 2.Pharmacotherapeutic Group, Department of Clinical Pharmacy and Pharmacy ManagementUniversity of NigeriaNsukkaNigeria

Personalised recommendations